The U.S. remains one of the most attractive growth markets in the world. PwC’s 2026 Global CEO Survey found that 51% of CEOs plan international investment in the year ahead, and 35% place the United States among their top three destinations. The attraction is understandable: scale, sophisticated buyers, deep capital markets, and large pools of commercial opportunity. But attractiveness and transferability are two different questions.

Across my career working with global B2B organizations, I have seen strong companies enter new markets with a reasonable assumption: if the business model has produced growth at home, the task abroad is to reproduce it with local sales coverage, translated materials, and more investment. That logic is appealing because it treats expansion as replication. In practice, however, successful market entry is closer to reconstruction.

The company must determine which elements of its success are intrinsic to the business, such as product advantage, technical capability, operating discipline, and also which were reinforced by conditions that may disappear at the border: brand familiarity, customer relationships, channel power, pricing norms, procurement expectations, regulatory pathways, or accumulated trust.

The status quo gets the diagnosis backwards

Most market-entry discussions today begin by asking: “How do we adapt what already works?”. I would rather start one step earlier with “Why does it work today?”. The distinction matters. McKinsey’s research on international growth makes the point succinctly. Companies should “go global if you can beat local.” Its analysis also warns that executives can become overly confident in the assets and capabilities that made them successful at home, assuming those same strengths will be sufficient in a new market. The issue, then, is not simply localization. It is understanding the causal system behind growth.

A home-market growth model is usually an interconnected set of advantages. Remove one or two (eg. familiar references, a trusted distributor, a short sales cycle, established procurement terms) and the economics of the entire model can change. Before replicating the model, three key elements should be assessed separately:

• What is genuinely transferable: product capability, intellectual property, technical expertise, operating know-how.

• What must be rebuilt locally: credibility, buyer understanding, proof, channels, relationships, commercial terms.

• What must be redesigned: positioning, pricing, sales motion, demand generation, partnerships, and the sequence of investment.

1 Home-market success hides the work that context is doing for you

At home, years of accumulated context make selling easier in ways that are difficult to see from inside the organization. Customers may already know the category. Your references carry weight. Channel partners understand where you fit. Procurement is familiar with your terms. Employees know how decisions get made. Even your pricing may benefit from assumptions buyers already accept.

When a company enters the U.S., much of that invisible infrastructure resets. This is why I am cautious when I hear leadership teams say, “We know this customer. We sell to the same profile in our home market.” The company may know the job title. It does not necessarily know the buying system around that person. The critical questions to pressure-test are straightforward:

• Does the U.S. buyer define the problem the same way?

• Do the proof points that establish credibility at home carry any weight here?

• Who else influences or can veto the purchase?

• What has to be true for a new supplier to be considered low enough risk to engage?

2 The biggest competitive gap is credibility, not product

International companies often enter the U.S. believing the competitive question is whether their product performs well enough. In many B2B categories, that is only the starting point. The more consequential question is whether the buying organization is comfortable taking a risk on an unfamiliar supplier.

The 2025 Edelman–LinkedIn B2B Thought Leadership research reinforces how complex that trust equation has become. More than 40% of B2B deals stall because of misalignment within buying groups, and “hidden buyers” can influence outcomes despite having little or no direct interaction with sales. The research also shows that high-quality thought leadership can help lesser-known companies earn advocacy from those stakeholders.

For a new entrant, this has an important implication. Brand readiness is not a communications issue sitting beside the commercial strategy. It is part of the commercial strategy. The better product does not always win. It loses when the buyer cannot quickly answer a few simple questions: Who are you? Who else trusts you? Where have you done this before? And what happens if something goes wrong?

3 Replicating the sales model can reproduce the wrong economics

One of the most dangerous assumptions in expansion is thinking that the home-market commercial engine can be translated into U.S. revenue by changing the geography in the spreadsheet. Customer acquisition cost, sales-cycle length, channel margins, compensation, legal review, implementation requirements, and the time required to create a credible reference customer can all behave very differently.

That means a model that is profitable at home can become capital-intensive in the U.S. even when the product is selling. This is where market entry becomes a capital-allocation question, not simply a sales target, and it becomes critical for the organization addressing the following topics:

• What a realistic U.S. sales cycle looks like, not the home-market cycle adjusted by assumption.

• What it will cost to create, qualify, and convert demand.

• Which customer segment can produce the first credible proof fastest.

• What commercial milestones justify the next tranche of investment.

• What evidence would cause the company to narrow, redesign, or stop the approach.

4 Localization is not the objective; market fit is

This is where my perspective differs from much of the conventional thinking on international expansion. Localization is important, but “localize the website, pricing, message, and sales materials” is usually treated as another checklist. A company can localize extensively and still preserve the wrong underlying assumptions.

The real objective is commercial fit. Clear alignment between what the company offers and how the target market evaluates, buys, implements, and renews it. Sometimes that requires significant localization. Sometimes the product changes very little but the proof, packaging, route to market, and sales motion change substantially.

The answer should come ultimately from evidence, not from a predetermined localization playbook. A better sequence in this case starts with validating the buyer and the problem, testing the value proposition and sources of differentiation, confirming the route to market and buying process, rebuilding the proof required to reduce perceived risk, validating the commercial economics, and only then scale the parts of the model that have earned the right to scale.

5 The first objective is not replication. It is learning what deserves to be replicated.

This changes how a successful first phase of U.S. expansion is defined. The goal is not to reproduce the home-market organization as quickly as possible. It is to determine, with limited capital at risk, which assumptions survive contact with the U.S. market. This requires leadership to treat early commercial activity as both revenue generation and structured learning.

PwC’s latest CEO research provides some useful context. The United States remains the leading destination for international investment, yet the same survey highlights execution discipline as a weakness. Only about one in four CEOs report having disciplined processes to stop underperforming innovation initiatives, tolerate high risk in innovation projects, or operate formal innovation structures.

The broader lesson applies directly to market entry. Ambition to invest is not the scarce resource. The discipline to test, learn, and redirect capital is.

The implications for leadership

A strong track record should increase confidence, but it should not lower the standard of proof for a new market. In fact, successful companies may need more discipline precisely because past success creates a powerful internal reference point. The organization knows what good looks like, but it may be looking at the wrong market.

Before asking how to replicate the growth model in the U.S., the more important task is to determine which elements of your home-market success are truly portable.

The company should then identify which advantages disappear when brand familiarity and relationships reset, what U.S. buyers will require it to prove again, and which parts of the commercial model need to be rebuilt rather than simply translated. Only then should the organization decide what evidence must be in place before accelerating investment.

That is the distinction between exporting a business model and building a market-entry model. One assumes the conditions for success will travel; the other tests, adapts, and rebuilds them for the market you are actually entering.